By Shalini Bhardwaj
New Delhi [India], August 6 (ANI): A global leader in medical diagnostics, Atellica announced the implementation of the new Atellica CI, independent integrated diagnostic testing analyzer at Imaging Centre & Labs, to make patient care more predictable and agile in today’s evolving healthcare landscape.
The latest technology-based analyzer is faster and more accurate that gives results in a few minutes.
Dr Harsh Mahajan, founder and Chief Radiologist of Mahajan Imaging & Labs, explained about the Atellica CI Analyzer which is useful and plays pivotal role in decision making for various medical conditions,
“Being the first to implement the Atellica CI Analyzer is a significant milestone for us and further strengthens our foray into pathology and integrated diagnostics,” he said.
Liver disease is now of utmost importance in our country. By combining the ELF test with the High End Ultrasound guided Fibro scan, we can very precisely know the current functional and structural status, and predict the onset of Liver disease, non-invasively,” he said.
“This analyzer is designed to significantly enhance patient comfort by providing faster, more accurate results. Mahajan Imaging & Labs, India’s medical imaging and diagnostics provider, continues to lead the way in integrated diagnostics while adopting advanced technologies that improve both the diagnostic experience and overall patient well-being,” claim experts.
The new Atellica CI Analyzer is a marvel of medical technology in a compact footprint, capable of analyzing over 200 parameters, covering 20 disease states. The analyzer’s microvolume technology maximizes test yield from a single sample aspiration. This feature is particularly beneficial for pediatric and critical cases where low-volume sample testing is essential. The analyzer’s ability to process critical tests within 14 minutes–compared to the conventional 22 to 40 minutes–sets a new standard for rapid diagnostics.
Ranabir Sinha, Head of Diagnostics – Zone India, Siemens Healthineers, said, “Installation of this innovative solution, powered by AI, reflects our shared vision of leveraging advanced technology to augment and enhance the capability of healthcare professionals and improve healthcare outcomes.”
Dr Shelly Mahajan, Lab Director and Clinical Lead of Mahajan Imaging & Labs further said, “We have rigorously validated the analyzer over the last 5 months in our reference lab at Mahajan Imaging & Labs. The analyzer helps us to enable predictive care to the patients, secure data, ensure a quick Turn Around Time (TAT) all while reaching environmental goals. This new analyzer is not only a game-changer for current diagnostics but ensures streamlined workflow and precise diagnostics. The analyzer is equipped with Laboratory Evaluation Suite and delivers inspection-ready reports. This forward-thinking approach ensures that we remain at the forefront of diagnostic innovation, continuously improving patient care standards.”
This advanced analyzer has been approved by the U.S. Food and Drug Administration (FDA) thereby confirm the analyzers’ and Mahajan Imaging & Labs‘ adherence to the highest international standards of safety, effectiveness, and reliability. (ANI)
